nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—BCHE—Irinotecan—lung cancer	0.123	0.291	CbGbCtD
Pancuronium—SLC22A2—Vinblastine—lung cancer	0.104	0.246	CbGbCtD
Pancuronium—BCHE—Cisplatin—lung cancer	0.1	0.237	CbGbCtD
Pancuronium—SLC22A2—Cisplatin—lung cancer	0.0953	0.226	CbGbCtD
Pancuronium—CHRND—pericardium—lung cancer	0.0374	0.446	CbGeAlD
Pancuronium—Respiratory insufficiency—Pemetrexed—lung cancer	0.0173	0.0984	CcSEcCtD
Pancuronium—BCHE—diaphragm—lung cancer	0.0171	0.204	CbGeAlD
Pancuronium—CHRNA2—mammary gland—lung cancer	0.0074	0.0884	CbGeAlD
Pancuronium—CHRND—respiratory system—lung cancer	0.00712	0.085	CbGeAlD
Pancuronium—Respiratory failure—Crizotinib—lung cancer	0.00581	0.0331	CcSEcCtD
Pancuronium—Salivation—Irinotecan—lung cancer	0.00569	0.0325	CcSEcCtD
Pancuronium—Drug interaction—Gefitinib—lung cancer	0.00558	0.0318	CcSEcCtD
Pancuronium—Respiratory failure—Pemetrexed—lung cancer	0.00531	0.0303	CcSEcCtD
Pancuronium—Respiratory failure—Gefitinib—lung cancer	0.00527	0.0301	CcSEcCtD
Pancuronium—CHRND—lung—lung cancer	0.00378	0.0452	CbGeAlD
Pancuronium—Muscular weakness—Crizotinib—lung cancer	0.00365	0.0208	CcSEcCtD
Pancuronium—Drug interaction—Erlotinib—lung cancer	0.00334	0.019	CcSEcCtD
Pancuronium—Respiratory failure—Topotecan—lung cancer	0.00319	0.0182	CcSEcCtD
Pancuronium—Respiratory failure—Vinorelbine—lung cancer	0.00273	0.0155	CcSEcCtD
Pancuronium—Redness—Paclitaxel—lung cancer	0.00267	0.0152	CcSEcCtD
Pancuronium—Bronchospasm—Teniposide—lung cancer	0.00261	0.0149	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Topotecan—lung cancer	0.00235	0.0134	CcSEcCtD
Pancuronium—Drug interaction—Gemcitabine—lung cancer	0.00232	0.0132	CcSEcCtD
Pancuronium—Erythema—Pemetrexed—lung cancer	0.00228	0.013	CcSEcCtD
Pancuronium—Redness—Docetaxel—lung cancer	0.00226	0.0129	CcSEcCtD
Pancuronium—Respiratory failure—Gemcitabine—lung cancer	0.00219	0.0125	CcSEcCtD
Pancuronium—Apnoea—Etoposide—lung cancer	0.00217	0.0123	CcSEcCtD
Pancuronium—Salivary hypersecretion—Irinotecan—lung cancer	0.00214	0.0122	CcSEcCtD
Pancuronium—Flushing—Teniposide—lung cancer	0.00197	0.0112	CcSEcCtD
Pancuronium—BCHE—respiratory system—lung cancer	0.00196	0.0234	CbGeAlD
Pancuronium—Drug interaction—Paclitaxel—lung cancer	0.00194	0.0111	CcSEcCtD
Pancuronium—Anaphylactic shock—Pemetrexed—lung cancer	0.00186	0.0106	CcSEcCtD
Pancuronium—Respiratory failure—Paclitaxel—lung cancer	0.00183	0.0105	CcSEcCtD
Pancuronium—Hypotension—Gefitinib—lung cancer	0.00173	0.00984	CcSEcCtD
Pancuronium—Muscular weakness—Vinorelbine—lung cancer	0.00171	0.00977	CcSEcCtD
Pancuronium—CHRNB1—lymph node—lung cancer	0.00167	0.0199	CbGeAlD
Pancuronium—Anaphylactoid reaction—Irinotecan—lung cancer	0.00166	0.00944	CcSEcCtD
Pancuronium—Bronchospasm—Vinorelbine—lung cancer	0.00165	0.00942	CcSEcCtD
Pancuronium—Drug interaction—Docetaxel—lung cancer	0.00165	0.00938	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Gemcitabine—lung cancer	0.00161	0.00919	CcSEcCtD
Pancuronium—BCHE—bronchus—lung cancer	0.00161	0.0192	CbGeAlD
Pancuronium—Paralysis—Methotrexate—lung cancer	0.00158	0.00902	CcSEcCtD
Pancuronium—Respiratory failure—Docetaxel—lung cancer	0.00155	0.00886	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Cisplatin—lung cancer	0.0015	0.00857	CcSEcCtD
Pancuronium—Tachycardia—Teniposide—lung cancer	0.00147	0.00838	CcSEcCtD
Pancuronium—BCHE—trachea—lung cancer	0.00145	0.0173	CbGeAlD
Pancuronium—Redness—Doxorubicin—lung cancer	0.00141	0.00804	CcSEcCtD
Pancuronium—Hypotension—Teniposide—lung cancer	0.00141	0.00802	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Etoposide—lung cancer	0.00138	0.00785	CcSEcCtD
Pancuronium—Paralysis—Doxorubicin—lung cancer	0.00137	0.00781	CcSEcCtD
Pancuronium—Hypersensitivity—Pemetrexed—lung cancer	0.00137	0.00781	CcSEcCtD
Pancuronium—Hypersensitivity—Gefitinib—lung cancer	0.00136	0.00776	CcSEcCtD
Pancuronium—BCHE—cardiac atrium—lung cancer	0.00136	0.0162	CbGeAlD
Pancuronium—Erythema—Erlotinib—lung cancer	0.00135	0.00771	CcSEcCtD
Pancuronium—Bronchospasm—Gemcitabine—lung cancer	0.00133	0.00756	CcSEcCtD
Pancuronium—Apnoea—Methotrexate—lung cancer	0.0013	0.0074	CcSEcCtD
Pancuronium—Rash—Crizotinib—lung cancer	0.00128	0.00731	CcSEcCtD
Pancuronium—Dermatitis—Crizotinib—lung cancer	0.00128	0.00731	CcSEcCtD
Pancuronium—Flushing—Vinorelbine—lung cancer	0.00125	0.00711	CcSEcCtD
Pancuronium—Rash—Pemetrexed—lung cancer	0.00117	0.00668	CcSEcCtD
Pancuronium—Dermatitis—Pemetrexed—lung cancer	0.00117	0.00668	CcSEcCtD
Pancuronium—Erythema—Vinorelbine—lung cancer	0.00117	0.00667	CcSEcCtD
Pancuronium—Rash—Gefitinib—lung cancer	0.00117	0.00664	CcSEcCtD
Pancuronium—Dermatitis—Gefitinib—lung cancer	0.00116	0.00663	CcSEcCtD
Pancuronium—Muscular weakness—Paclitaxel—lung cancer	0.00115	0.00657	CcSEcCtD
Pancuronium—BCHE—bone marrow—lung cancer	0.00115	0.0137	CbGeAlD
Pancuronium—Bronchospasm—Etoposide—lung cancer	0.00113	0.00646	CcSEcCtD
Pancuronium—Respiratory failure—Methotrexate—lung cancer	0.00112	0.00638	CcSEcCtD
Pancuronium—Anaphylactic shock—Topotecan—lung cancer	0.00112	0.00636	CcSEcCtD
Pancuronium—Hypersensitivity—Teniposide—lung cancer	0.00111	0.00633	CcSEcCtD
Pancuronium—BCHE—lung—lung cancer	0.00104	0.0124	CbGeAlD
Pancuronium—Flushing—Irinotecan—lung cancer	0.00103	0.00586	CcSEcCtD
Pancuronium—Anaphylactic shock—Vinorelbine—lung cancer	0.000955	0.00544	CcSEcCtD
Pancuronium—Rash—Teniposide—lung cancer	0.00095	0.00541	CcSEcCtD
Pancuronium—Dermatitis—Teniposide—lung cancer	0.000949	0.00541	CcSEcCtD
Pancuronium—Bronchospasm—Docetaxel—lung cancer	0.000942	0.00537	CcSEcCtD
Pancuronium—Erythema—Gemcitabine—lung cancer	0.00094	0.00536	CcSEcCtD
Pancuronium—Flushing—Cisplatin—lung cancer	0.000934	0.00532	CcSEcCtD
Pancuronium—Tachycardia—Vinorelbine—lung cancer	0.000932	0.00531	CcSEcCtD
Pancuronium—Salivary hypersecretion—Doxorubicin—lung cancer	0.000925	0.00527	CcSEcCtD
Pancuronium—Hypotension—Vinorelbine—lung cancer	0.000892	0.00509	CcSEcCtD
Pancuronium—Erythema—Cisplatin—lung cancer	0.000876	0.00499	CcSEcCtD
Pancuronium—Flushing—Etoposide—lung cancer	0.000856	0.00488	CcSEcCtD
Pancuronium—Hypersensitivity—Vinblastine—lung cancer	0.000847	0.00483	CcSEcCtD
Pancuronium—Flushing—Paclitaxel—lung cancer	0.000839	0.00478	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Methotrexate—lung cancer	0.000825	0.0047	CcSEcCtD
Pancuronium—Hypersensitivity—Topotecan—lung cancer	0.000823	0.00469	CcSEcCtD
Pancuronium—Anaphylactic shock—Irinotecan—lung cancer	0.000788	0.00449	CcSEcCtD
Pancuronium—Erythema—Paclitaxel—lung cancer	0.000787	0.00449	CcSEcCtD
Pancuronium—Anaphylactic shock—Gemcitabine—lung cancer	0.000767	0.00437	CcSEcCtD
Pancuronium—Hypotension—Irinotecan—lung cancer	0.000736	0.0042	CcSEcCtD
Pancuronium—Hypotension—Gemcitabine—lung cancer	0.000717	0.00409	CcSEcCtD
Pancuronium—Anaphylactic shock—Cisplatin—lung cancer	0.000715	0.00408	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000714	0.00407	CcSEcCtD
Pancuronium—Flushing—Docetaxel—lung cancer	0.000711	0.00405	CcSEcCtD
Pancuronium—BCHE—lymph node—lung cancer	0.00071	0.00848	CbGeAlD
Pancuronium—Rash—Topotecan—lung cancer	0.000704	0.00401	CcSEcCtD
Pancuronium—Hypersensitivity—Vinorelbine—lung cancer	0.000704	0.00401	CcSEcCtD
Pancuronium—Dermatitis—Topotecan—lung cancer	0.000703	0.00401	CcSEcCtD
Pancuronium—Tachycardia—Cisplatin—lung cancer	0.000698	0.00398	CcSEcCtD
Pancuronium—Rash—Erlotinib—lung cancer	0.000697	0.00397	CcSEcCtD
Pancuronium—Dermatitis—Erlotinib—lung cancer	0.000696	0.00397	CcSEcCtD
Pancuronium—Hypotension—Cisplatin—lung cancer	0.000668	0.00381	CcSEcCtD
Pancuronium—Erythema—Docetaxel—lung cancer	0.000667	0.0038	CcSEcCtD
Pancuronium—Anaphylactic shock—Etoposide—lung cancer	0.000655	0.00373	CcSEcCtD
Pancuronium—Anaphylactic shock—Paclitaxel—lung cancer	0.000642	0.00366	CcSEcCtD
Pancuronium—Tachycardia—Etoposide—lung cancer	0.000639	0.00364	CcSEcCtD
Pancuronium—Tachycardia—Paclitaxel—lung cancer	0.000627	0.00357	CcSEcCtD
Pancuronium—Hypotension—Etoposide—lung cancer	0.000612	0.00349	CcSEcCtD
Pancuronium—Muscular weakness—Doxorubicin—lung cancer	0.00061	0.00348	CcSEcCtD
Pancuronium—Rash—Vinorelbine—lung cancer	0.000602	0.00343	CcSEcCtD
Pancuronium—Dermatitis—Vinorelbine—lung cancer	0.000602	0.00343	CcSEcCtD
Pancuronium—Hypotension—Paclitaxel—lung cancer	0.0006	0.00342	CcSEcCtD
Pancuronium—Hypersensitivity—Irinotecan—lung cancer	0.00058	0.00331	CcSEcCtD
Pancuronium—Anaphylactic shock—Docetaxel—lung cancer	0.000545	0.0031	CcSEcCtD
Pancuronium—Tachycardia—Docetaxel—lung cancer	0.000531	0.00303	CcSEcCtD
Pancuronium—Hypersensitivity—Cisplatin—lung cancer	0.000527	0.003	CcSEcCtD
Pancuronium—Hypotension—Docetaxel—lung cancer	0.000509	0.0029	CcSEcCtD
Pancuronium—Rash—Irinotecan—lung cancer	0.000497	0.00283	CcSEcCtD
Pancuronium—Dermatitis—Irinotecan—lung cancer	0.000496	0.00283	CcSEcCtD
Pancuronium—Rash—Gemcitabine—lung cancer	0.000484	0.00276	CcSEcCtD
Pancuronium—Dermatitis—Gemcitabine—lung cancer	0.000483	0.00275	CcSEcCtD
Pancuronium—Hypersensitivity—Etoposide—lung cancer	0.000483	0.00275	CcSEcCtD
Pancuronium—Erythema—Methotrexate—lung cancer	0.000481	0.00274	CcSEcCtD
Pancuronium—Hypersensitivity—Paclitaxel—lung cancer	0.000473	0.0027	CcSEcCtD
Pancuronium—Rash—Cisplatin—lung cancer	0.000451	0.00257	CcSEcCtD
Pancuronium—Dermatitis—Cisplatin—lung cancer	0.000451	0.00257	CcSEcCtD
Pancuronium—Flushing—Doxorubicin—lung cancer	0.000444	0.00253	CcSEcCtD
Pancuronium—Erythema—Doxorubicin—lung cancer	0.000416	0.00237	CcSEcCtD
Pancuronium—Rash—Etoposide—lung cancer	0.000413	0.00235	CcSEcCtD
Pancuronium—Dermatitis—Etoposide—lung cancer	0.000413	0.00235	CcSEcCtD
Pancuronium—Rash—Paclitaxel—lung cancer	0.000405	0.00231	CcSEcCtD
Pancuronium—Dermatitis—Paclitaxel—lung cancer	0.000405	0.00231	CcSEcCtD
Pancuronium—Hypersensitivity—Docetaxel—lung cancer	0.000401	0.00229	CcSEcCtD
Pancuronium—Anaphylactic shock—Methotrexate—lung cancer	0.000392	0.00224	CcSEcCtD
Pancuronium—Hypotension—Methotrexate—lung cancer	0.000367	0.00209	CcSEcCtD
Pancuronium—Rash—Docetaxel—lung cancer	0.000343	0.00196	CcSEcCtD
Pancuronium—Dermatitis—Docetaxel—lung cancer	0.000343	0.00196	CcSEcCtD
Pancuronium—Anaphylactic shock—Doxorubicin—lung cancer	0.00034	0.00194	CcSEcCtD
Pancuronium—Tachycardia—Doxorubicin—lung cancer	0.000332	0.00189	CcSEcCtD
Pancuronium—Hypotension—Doxorubicin—lung cancer	0.000318	0.00181	CcSEcCtD
Pancuronium—Hypersensitivity—Methotrexate—lung cancer	0.000289	0.00165	CcSEcCtD
Pancuronium—Hypersensitivity—Doxorubicin—lung cancer	0.00025	0.00143	CcSEcCtD
Pancuronium—Rash—Methotrexate—lung cancer	0.000247	0.00141	CcSEcCtD
Pancuronium—Dermatitis—Methotrexate—lung cancer	0.000247	0.00141	CcSEcCtD
Pancuronium—Rash—Doxorubicin—lung cancer	0.000214	0.00122	CcSEcCtD
Pancuronium—Dermatitis—Doxorubicin—lung cancer	0.000214	0.00122	CcSEcCtD
Pancuronium—Vecuronium—ABCB1—lung cancer	5.74e-05	1	CrCbGaD
Pancuronium—BCHE—Metabolism—CAT—lung cancer	2.62e-05	8.21e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.6e-05	8.17e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADCY1—lung cancer	2.6e-05	8.15e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—STK11—lung cancer	2.6e-05	8.15e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	2.56e-05	8.03e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PPP2R1B—lung cancer	2.56e-05	8.02e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SMARCA4—lung cancer	2.56e-05	8.02e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ABCB1—lung cancer	2.55e-05	7.99e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PPP2R1B—lung cancer	2.53e-05	7.94e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SMARCA4—lung cancer	2.53e-05	7.94e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP2E1—lung cancer	2.51e-05	7.87e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—TYMS—lung cancer	2.5e-05	7.85e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—NQO1—lung cancer	2.48e-05	7.78e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GSTM1—lung cancer	2.47e-05	7.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HSPB1—lung cancer	2.47e-05	7.74e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HSPB1—lung cancer	2.44e-05	7.66e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTHLH—lung cancer	2.44e-05	7.65e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—STK11—lung cancer	2.42e-05	7.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTHLH—lung cancer	2.42e-05	7.58e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GSTP1—lung cancer	2.4e-05	7.54e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CYP1A1—lung cancer	2.34e-05	7.35e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CAT—lung cancer	2.34e-05	7.33e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ERCC2—lung cancer	2.32e-05	7.29e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ANXA1—lung cancer	2.29e-05	7.19e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ABCB1—lung cancer	2.27e-05	7.14e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ANXA1—lung cancer	2.27e-05	7.12e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTP1—lung cancer	2.24e-05	7.03e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—STK11—lung cancer	2.24e-05	7.01e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—TYMS—lung cancer	2.23e-05	7.01e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FLT1—lung cancer	2.22e-05	6.97e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GSTM1—lung cancer	2.21e-05	6.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CG—lung cancer	2.2e-05	6.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FLT1—lung cancer	2.2e-05	6.9e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CAT—lung cancer	2.18e-05	6.84e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CG—lung cancer	2.18e-05	6.84e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APP—lung cancer	2.17e-05	6.82e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOTCH3—lung cancer	2.17e-05	6.82e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGF9—lung cancer	2.16e-05	6.76e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOTCH3—lung cancer	2.15e-05	6.75e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APP—lung cancer	2.15e-05	6.75e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGF9—lung cancer	2.14e-05	6.7e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ABCB1—lung cancer	2.12e-05	6.65e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—POMC—lung cancer	2.09e-05	6.57e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CYP1A1—lung cancer	2.09e-05	6.57e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—TYMS—lung cancer	2.08e-05	6.53e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ERCC2—lung cancer	2.08e-05	6.51e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—POMC—lung cancer	2.07e-05	6.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTP1—lung cancer	2.07e-05	6.49e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUNB—lung cancer	2.06e-05	6.46e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTM1—lung cancer	2.06e-05	6.46e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUNB—lung cancer	2.04e-05	6.4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CAT—lung cancer	2.01e-05	6.32e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—APOA1—lung cancer	2.01e-05	6.31e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CG—lung cancer	2e-05	6.27e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CG—lung cancer	1.98e-05	6.21e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ABCB1—lung cancer	1.96e-05	6.14e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CYP1A1—lung cancer	1.95e-05	6.12e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ERCC2—lung cancer	1.94e-05	6.07e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CD—lung cancer	1.93e-05	6.07e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.93e-05	6.04e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—TYMS—lung cancer	1.92e-05	6.03e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CD—lung cancer	1.92e-05	6.01e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—POMC—lung cancer	1.9e-05	5.97e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTM1—lung cancer	1.9e-05	5.96e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—POMC—lung cancer	1.88e-05	5.91e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STK11—lung cancer	1.87e-05	5.86e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6R—lung cancer	1.86e-05	5.82e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STK11—lung cancer	1.85e-05	5.81e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6R—lung cancer	1.84e-05	5.76e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CG—lung cancer	1.84e-05	5.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FOXO3—lung cancer	1.8e-05	5.66e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP1A1—lung cancer	1.8e-05	5.65e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—APOA1—lung cancer	1.8e-05	5.63e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ERCC2—lung cancer	1.79e-05	5.61e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FOXO3—lung cancer	1.79e-05	5.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAP2K1—lung cancer	1.77e-05	5.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CD—lung cancer	1.76e-05	5.51e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAP2K1—lung cancer	1.75e-05	5.49e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—POMC—lung cancer	1.75e-05	5.48e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CD—lung cancer	1.74e-05	5.46e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CREBBP—lung cancer	1.7e-05	5.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AVP—lung cancer	1.69e-05	5.3e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	1.69e-05	5.29e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AVP—lung cancer	1.67e-05	5.25e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—APOA1—lung cancer	1.67e-05	5.25e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CB—lung cancer	1.67e-05	5.24e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CG—lung cancer	1.64e-05	5.14e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1R—lung cancer	1.63e-05	5.11e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	1.62e-05	5.08e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CD—lung cancer	1.61e-05	5.06e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1R—lung cancer	1.61e-05	5.06e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—CXCL8—lung cancer	1.6e-05	5.03e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HES1—lung cancer	1.6e-05	5.02e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ALB—lung cancer	1.59e-05	5e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HES1—lung cancer	1.58e-05	4.97e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—RAF1—lung cancer	1.57e-05	4.92e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—POMC—lung cancer	1.56e-05	4.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—RAF1—lung cancer	1.55e-05	4.87e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—IL2—lung cancer	1.55e-05	4.86e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—APOA1—lung cancer	1.55e-05	4.85e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—IL2—lung cancer	1.53e-05	4.81e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	1.53e-05	4.8e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CG—lung cancer	1.53e-05	4.79e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CREBBP—lung cancer	1.52e-05	4.77e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	1.52e-05	4.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CXCL8—lung cancer	1.47e-05	4.62e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB3—lung cancer	1.46e-05	4.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CXCL8—lung cancer	1.46e-05	4.57e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—POMC—lung cancer	1.45e-05	4.56e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB3—lung cancer	1.45e-05	4.54e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CD—lung cancer	1.44e-05	4.52e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ALB—lung cancer	1.42e-05	4.46e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CREBBP—lung cancer	1.42e-05	4.44e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CG—lung cancer	1.41e-05	4.43e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CB—lung cancer	1.41e-05	4.41e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL2—lung cancer	1.41e-05	4.41e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TERT—lung cancer	1.4e-05	4.39e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS2—lung cancer	1.39e-05	4.37e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL2—lung cancer	1.39e-05	4.37e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TERT—lung cancer	1.39e-05	4.35e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—FGFR1—lung cancer	1.36e-05	4.27e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—FGFR1—lung cancer	1.35e-05	4.23e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—POMC—lung cancer	1.34e-05	4.22e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CD—lung cancer	1.34e-05	4.21e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HIF1A—lung cancer	1.34e-05	4.2e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HIF1A—lung cancer	1.33e-05	4.16e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALB—lung cancer	1.33e-05	4.16e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CREBBP—lung cancer	1.31e-05	4.11e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APOA1—lung cancer	1.29e-05	4.06e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KDR—lung cancer	1.28e-05	4.02e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APOA1—lung cancer	1.28e-05	4.02e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KDR—lung cancer	1.27e-05	3.98e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CB—lung cancer	1.26e-05	3.94e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS2—lung cancer	1.24e-05	3.91e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CD—lung cancer	1.24e-05	3.89e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALB—lung cancer	1.23e-05	3.84e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTEN—lung cancer	1.22e-05	3.81e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APC—lung cancer	1.18e-05	3.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CG—lung cancer	1.18e-05	3.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KIT—lung cancer	1.18e-05	3.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—NRAS—lung cancer	1.18e-05	3.7e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CB—lung cancer	1.17e-05	3.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CG—lung cancer	1.17e-05	3.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KIT—lung cancer	1.17e-05	3.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APC—lung cancer	1.17e-05	3.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—NRAS—lung cancer	1.17e-05	3.67e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EGF—lung cancer	1.17e-05	3.66e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS2—lung cancer	1.16e-05	3.64e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—EP300—lung cancer	1.16e-05	3.64e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EGF—lung cancer	1.16e-05	3.62e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—MAPK3—lung cancer	1.13e-05	3.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—POMC—lung cancer	1.12e-05	3.52e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—MAPK3—lung cancer	1.12e-05	3.51e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—POMC—lung cancer	1.11e-05	3.49e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—BRAF—lung cancer	1.11e-05	3.48e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—BRAF—lung cancer	1.1e-05	3.45e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6R—lung cancer	1.1e-05	3.44e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CREBBP—lung cancer	1.09e-05	3.43e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTEN—lung cancer	1.09e-05	3.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6R—lung cancer	1.09e-05	3.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CREBBP—lung cancer	1.08e-05	3.4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CB—lung cancer	1.08e-05	3.39e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—EGFR—lung cancer	1.08e-05	3.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS2—lung cancer	1.07e-05	3.36e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—EGFR—lung cancer	1.07e-05	3.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAP2K1—lung cancer	1.04e-05	3.28e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CD—lung cancer	1.04e-05	3.26e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—EP300—lung cancer	1.04e-05	3.25e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAP2K1—lung cancer	1.03e-05	3.24e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	1.03e-05	3.22e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CD—lung cancer	1.03e-05	3.22e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	1.02e-05	3.19e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—KRAS—lung cancer	1.02e-05	3.19e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTEN—lung cancer	1.01e-05	3.17e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—KRAS—lung cancer	1.01e-05	3.16e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—EP300—lung cancer	9.65e-06	3.03e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTEN—lung cancer	9.35e-06	2.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	9.33e-06	2.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MDM2—lung cancer	9.3e-06	2.92e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RAF1—lung cancer	9.27e-06	2.91e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	9.24e-06	2.9e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MDM2—lung cancer	9.21e-06	2.89e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RAF1—lung cancer	9.18e-06	2.88e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ERBB2—lung cancer	9.17e-06	2.88e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ERBB2—lung cancer	9.08e-06	2.85e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CB—lung cancer	9.05e-06	2.84e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MTOR—lung cancer	9.05e-06	2.84e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CB—lung cancer	8.96e-06	2.81e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MTOR—lung cancer	8.96e-06	2.81e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—EP300—lung cancer	8.91e-06	2.8e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CXCL8—lung cancer	8.69e-06	2.73e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—HRAS—lung cancer	8.64e-06	2.71e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CXCL8—lung cancer	8.61e-06	2.7e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3CA—lung cancer	8.58e-06	2.69e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—HRAS—lung cancer	8.55e-06	2.68e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT1—lung cancer	8.4e-06	2.63e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP3—lung cancer	8.32e-06	2.61e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT1—lung cancer	8.32e-06	2.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL2—lung cancer	8.31e-06	2.61e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6—lung cancer	8.27e-06	2.59e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP3—lung cancer	8.24e-06	2.58e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL2—lung cancer	8.23e-06	2.58e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6—lung cancer	8.19e-06	2.57e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCND1—lung cancer	8.1e-06	2.54e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—JUN—lung cancer	8.08e-06	2.53e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCND1—lung cancer	8.02e-06	2.52e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—JUN—lung cancer	8e-06	2.51e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MMP9—lung cancer	7.86e-06	2.47e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN1A—lung cancer	7.83e-06	2.46e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTEN—lung cancer	7.82e-06	2.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MMP9—lung cancer	7.79e-06	2.44e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN1A—lung cancer	7.76e-06	2.43e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTEN—lung cancer	7.74e-06	2.43e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3CA—lung cancer	7.66e-06	2.4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT1—lung cancer	7.63e-06	2.39e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT1—lung cancer	7.55e-06	2.37e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EP300—lung cancer	7.45e-06	2.34e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EP300—lung cancer	7.38e-06	2.32e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SRC—lung cancer	7.25e-06	2.27e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SRC—lung cancer	7.18e-06	2.25e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3CA—lung cancer	7.14e-06	2.24e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VEGFA—lung cancer	7.06e-06	2.21e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AKT1—lung cancer	7.01e-06	2.2e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VEGFA—lung cancer	6.99e-06	2.19e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—STAT3—lung cancer	6.99e-06	2.19e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NRAS—lung cancer	6.97e-06	2.19e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—STAT3—lung cancer	6.92e-06	2.17e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NRAS—lung cancer	6.91e-06	2.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MAPK3—lung cancer	6.68e-06	2.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MAPK3—lung cancer	6.61e-06	2.07e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3CA—lung cancer	6.59e-06	2.07e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MYC—lung cancer	6.5e-06	2.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MYC—lung cancer	6.43e-06	2.02e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EGFR—lung cancer	6.35e-06	1.99e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EGFR—lung cancer	6.29e-06	1.97e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AKT1—lung cancer	6.26e-06	1.96e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—KRAS—lung cancer	6e-06	1.88e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—KRAS—lung cancer	5.94e-06	1.86e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AKT1—lung cancer	5.83e-06	1.83e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3CA—lung cancer	5.51e-06	1.73e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3CA—lung cancer	5.46e-06	1.71e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AKT1—lung cancer	5.39e-06	1.69e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TP53—lung cancer	5.33e-06	1.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TP53—lung cancer	5.28e-06	1.66e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HRAS—lung cancer	5.1e-06	1.6e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HRAS—lung cancer	5.05e-06	1.58e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6—lung cancer	4.88e-06	1.53e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6—lung cancer	4.84e-06	1.52e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT1—lung cancer	4.5e-06	1.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT1—lung cancer	4.46e-06	1.4e-05	CbGpPWpGaD
